26 results
Drugs Used for the Treatment of COVID-19 Infection
LOPINAVIR / RITONAVIR
INTERFERON Beta-I
REMDESIVIR
HYDROXYCHLOROQUINE
TOCILIZUMAB

Piotr Okupski @PiotrOkupski - Original Infographic
the Treatment of COVID ... -19 Infection LOPINAVIR ... smfarmhosp_smfh #Drugs #Medications ... #Pharmacology #Table ... #Management
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Treatment Agents for COVID ... 2020 #Drugs #Medications ... #Treatment #COVID19 ... #Pharmacology #Table ... #Management #MGH
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
COVID-19: ICU Guidelines ... Non-Intensivist Infection ... Laboratory Workup COVID ... -19 Specific Medications ... NonIntensivist #diagnosis #management
Catecholamine Vasopressor Effect Sites and Indications #Pathophys #Management #EM #IM #PCC #Catecholamine #Comparison #Table #Epi #Norepi
Effect Sites and Indications ... #Pathophys #Management ... #EM #IM #PCC #Catecholamine ... #Comparison #Table
Summary of Infections in which Steroids play a role in treatment
 • TB meningitis
 • TB
Summary of Infections ... pneumonia • COVID ... (IRIS) (not an infection ... #Steroids #Indications ... #infections #management
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
the Treatment of COVID ... -19 Infection ... smfarmhosp_smfh #Drugs #Medications ... #Pharmacology #Table ... #Management
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
C virus (HCV) infection ... DAAs #Antivirals #table ... treatment #hcv #medications ... HepC #HepatitisC #Management
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Siltuximab) in COVID19 ... correlate with severe COVID ... respiratory tract infection ... #Pharmacology #Management ... #Medications
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Pulmonary fibrotic ... • HIV: 2/3 pulmonary ... destruction (including pulmonary ... staining, NAA (PCR ... TB #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Pulmonary fibrotic ... • HIV: 2/3 pulmonary ... destruction (including pulmonary ... staining, NAA (PCR ... TB #Diagnosis #Management